Cytokinetics | CYTK - Operating Expenses



Cytokinetics reported $178.28M in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
Acadia Pharmaceuticals USD 232.19M 7.16M Jun/2025
Amgen USD 6.52B 337M Jun/2025
Bayer EUR 10.73B 688M Jun/2025
Biogen USD 1.79B 326.1M Jun/2025
Bristol-Myers Squibb USD 8.5B 265M Jun/2025
Cytokinetics USD 178.28M 21.06M Jun/2025
Eisai JPY 181.91B 7.35B Jun/2025
Eli Lilly USD 8.54B 1.22B Jun/2025
Exelixis USD 354.68M 13.9M Jul/2025
Geron USD 61.49M 5.18M Jun/2025
Halozyme Therapeutics USD 123.28M 48K Jun/2025
Ionis Pharmaceuticals USD 312.21M 34.21M Jun/2025
Ligand Pharmaceuticals USD 40.46M 41.09M Jun/2025
Merck USD 9.44B 217M Jun/2025
Novartis USD 9.97B 1.02B Jun/2025
Pfizer USD 11.62B 1.58B Jun/2025
Regeneron Pharmaceuticals USD 2.6B 159.1M Jun/2025
Roche Holding CHF 11.43B 1.48B Dec/2024
Sanofi EUR 9.02B 702M Jun/2025